Clear Search

Showing 1 result for “Xu Y” published 2022.

October 2022

Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease

Front Pharmacol. 2022;13:967317 DOI: 10.3389/fphar.2022.967317

A network meta-analysis has found that newer mineralocorticoid receptor antagonists (MRAs) appear to have greater efficacy in reducing urine albumin creatinine ratio (UACR) vs baseline than traditional MRAs in the treatment of diabetic kidney disease (DKD).

more…